Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-20T17:07:56.104Z Has data issue: false hasContentIssue false

Cytochrome P450 System Activity in Alcoholic Patients From Different Ethnic Groups

Published online by Cambridge University Press:  15 April 2020

V.F. Lebedeva
Affiliation:
Clinics, Mental Health Research Institute SB RAMSci, Tomsk, Russia
T.V. Shushpanova
Affiliation:
Laboratory of Clinical Psychoneuroimmunology and Neurobiology, Mental Health Research Institute SB RAMSci, Tomsk, Russia
T.P. Novozheeva
Affiliation:
Laboratory of Clinical Psychoneuroimmunology and Neurobiology, Mental Health Research Institute SB RAMSci, Tomsk, Russia
N.A. Bokhan
Affiliation:
Addictive States Department, Mental Health Research Institute SB RAMSci, Tomsk, Russia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

Sensitization of cytochrome P-450 system to action of alcohol can become a significant problem of psychopharmacotherapy. M-chlor-benzhydrylurea – Galodif® is an efficient anticonvulsant. We investigated effect of Galodif on activity of the liver cytochrome P450 system of alcoholics from two different ethnic groups.

Methods

As a test-drug antipirine was used. 68 patients (from Russian and Tatar ethnic groups) were examined. The concentration of test-drug antipirine in saliva was determined by spectrophotometry assay. Pharmacokinetic parameters were counted by model-independent method of statistical moments by K. Yamaoka: period of half-elimination (T1/2, h), total clearance (Cl t, ml/min), middle time of residual drug in organism (MRT, h), middle time of elimination (MET, h), area under the pharmacokinetic curve (AUC, mkgh/ml).

Results

Clinical monitoring provides a possibility to considerably optimize the process of treatment of alcoholic patients. We observed, that T1/2 of drug kinetic was 8,81±5,23 before treatment and 4,37±2,31* after treatment with Galodif; Clt: 113,42±38,67 and 137,37±54,00; MRT: 11,44±5,43 and 3,69±0,60* (p<0.05); MET: 6,03±2,10 and 4,64±1,83* (p<0.05); AUC: 7,05±5,74 and 6,39±2,18, respectively. Galodif causes reduction of period of half-elimination, significant decrease of middle time of residual drug in organism and middle elimination time. Drug pharmacokinetics parameters in alcoholic patients from Tatar ethnic group were as follows: T1/2: 11,19±2,95 and 2,57±0,69*; Clt: 71,108±11,58 and 116,23±9,40*; MRT: 8,66±1,13 and 2,60±0,46*; MET (h) 5,71±0,57 and 3,68±0,49*; AUC: 11,58±1,71 and 7,30±1,04*, respectively.

Conclusion

These data suggest that the individual sensitivity of organism to the drug is caused not only by biochemical, but also by anthropo-morpho-physiological polymorphism.

Type
Article: 0833
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.